Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuhiro Nakashima

Showing results (81-90 of 171) with videos related to

Pageof 18
Sort By:
American Journal of Physiology. Heart and Circulatory Physiology|November 1, 2015
Heterozygous deletion of sarcolipin maintains normal cardiac functionDaisuke Shimura, Yoichiro Kusakari, Tetsuo Sasano, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 9, 2020
[Erythrocytosis following allogeneic hematopoietic stem cell transplantation]Hiroe Kawahara, Teruhito Takakuwa, Mika Nakamae, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 23, 2014
Cerebral toxoplasmosis after umbilical cord blood transplantation diagnosed by the detection of anti-toxoplasma specific IgM antibody in cerebrospinal fluidAkiko Inaba, Hideo Koh, Yasuhiro Nakashima, et al.
Cell Transplantation|July 30, 2022
A Prospective Study of an HLA-Haploidentical Peripheral Blood Stem Cell Transplantation Regimen Based on Modification of the Dose of Posttransplant Cyclophosphamide for Poor Prognosis or Refractory Hematological MalignanciesHirohisa Nakamae, Hiroshi Okamura, Asao Hirose, et al.
Immunotherapy|November 11, 2021
Delayed immune-related neutropenia with hepatitis by pembrolizumabSoichiro Nakako, Yasuhiro Nakashima, Hiroshi Okamura, et al.
International Journal of Hematology|April 7, 2026
Ten-color multicolor flow cytometry-based measurable residual disease at pre-transplantation predicts relapse of acute myeloid leukemia: a prospective studyKumiyo Tazoe, Hirohisa Nakamae, Yosuke Makuuchi, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 14, 2019
Pretransplant serum beta-2 microglobulin level is a potential novel prognostic marker of overall survival after allogeneic hematopoietic cell transplantation - a retrospective observational studyNaonori Harada, Takahiko Nakane, Mika Nakamae, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 5, 2021
[Diffuse large B-cell lymphoma with markedly improved chylothorax by lymphangiography]Makoto Moriguchi, Teruhito Takakuwa, Ken Kageyama, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 18, 2020
Effect of Prophylactic Post-transplant Ponatinib Administration on Outcomes in Patients With Philadelphia Chromosome-positive Acute Lymphoblastic LeukemiaSatoru Nanno, Kana Matsumoto, Mika Nakamae, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|June 8, 2020
Clinical usefulness of very high serum soluble interleukin-2 receptor levels for the detection of tuberculous peritonitis in a patient with chronic myelogenous leukemiaMakoto Moriguchi, Hideo Koh, Tetsuya Hayashi, et al.
Pageof 18

Showing results (81-90 of 171) with videos related to

Sort By:
Pageof 18
American Journal of Physiology. Heart and Circulatory Physiology|November 1, 2015
Heterozygous deletion of sarcolipin maintains normal cardiac functionDaisuke Shimura, Yoichiro Kusakari, Tetsuo Sasano, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 9, 2020
[Erythrocytosis following allogeneic hematopoietic stem cell transplantation]Hiroe Kawahara, Teruhito Takakuwa, Mika Nakamae, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 23, 2014
Cerebral toxoplasmosis after umbilical cord blood transplantation diagnosed by the detection of anti-toxoplasma specific IgM antibody in cerebrospinal fluidAkiko Inaba, Hideo Koh, Yasuhiro Nakashima, et al.
Cell Transplantation|July 30, 2022
A Prospective Study of an HLA-Haploidentical Peripheral Blood Stem Cell Transplantation Regimen Based on Modification of the Dose of Posttransplant Cyclophosphamide for Poor Prognosis or Refractory Hematological MalignanciesHirohisa Nakamae, Hiroshi Okamura, Asao Hirose, et al.
Immunotherapy|November 11, 2021
Delayed immune-related neutropenia with hepatitis by pembrolizumabSoichiro Nakako, Yasuhiro Nakashima, Hiroshi Okamura, et al.
International Journal of Hematology|April 7, 2026
Ten-color multicolor flow cytometry-based measurable residual disease at pre-transplantation predicts relapse of acute myeloid leukemia: a prospective studyKumiyo Tazoe, Hirohisa Nakamae, Yosuke Makuuchi, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 14, 2019
Pretransplant serum beta-2 microglobulin level is a potential novel prognostic marker of overall survival after allogeneic hematopoietic cell transplantation - a retrospective observational studyNaonori Harada, Takahiko Nakane, Mika Nakamae, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 5, 2021
[Diffuse large B-cell lymphoma with markedly improved chylothorax by lymphangiography]Makoto Moriguchi, Teruhito Takakuwa, Ken Kageyama, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 18, 2020
Effect of Prophylactic Post-transplant Ponatinib Administration on Outcomes in Patients With Philadelphia Chromosome-positive Acute Lymphoblastic LeukemiaSatoru Nanno, Kana Matsumoto, Mika Nakamae, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|June 8, 2020
Clinical usefulness of very high serum soluble interleukin-2 receptor levels for the detection of tuberculous peritonitis in a patient with chronic myelogenous leukemiaMakoto Moriguchi, Hideo Koh, Tetsuya Hayashi, et al.
Pageof 18